Dasashil 70 mg Tablet
  1. Home
  2. Pharma Products
  3. shilpa medicare
  4. Dasashil 70 mg Tablet

Dasashil 70 mg Tablet

Dasashil 70 mg Tablet contains dasatinib 70 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor class. It is used to treat specific blood cancers, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The tablet is a prescription medicine and should be taken under the supervision of an oncologist.

BUY NOW

Category

Dasatinib works by inhibiting abnormal tyrosine kinase proteins, including BCR-ABL, that promote the growth and survival of leukemia cells. Dasashil 70 mg Tablet may be prescribed for patients with Philadelphia chromosome-positive leukemia according to the clinical condition and treatment protocol. The medicine is taken orally and may be administered with or without food as directed by the physician. Regular blood tests and medical monitoring may be required during treatment to assess blood counts and treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 70 mg
Dosage Form Tablet
Therapeutic Class Antineoplastic
Action Class Tyrosine Kinase Inhibitor
Pack Size 60 tablets

Product Also Known As

Dasashil 70 mg Tablet, Dasashil 70mg Tablet, Dasatinib 70 mg Tablet, Dasatinib 70mg Tablet, Dasatinib Anticancer Tablet, Dasatinib Leukemia Tablet, BCR-ABL Inhibitor Tablet